Bill > HF2533

This bill modifies Minnesota's prior authorization rules for prescription drugs, specifically focusing on mental health medications. The bill expands protections for central nervous system prescription drugs used to treat mental health conditions by prohibiting prior authorization or other utilization management controls for drugs classified as anticonvulsants, antidepressants, antipsychotics, or noncontrolled substance antianxiety medications. It defines "utilization management controls" as formal techniques used by health carriers to monitor and evaluate prescription drug use, including prior authorization and step therapy protocols. The bill also introduces an automatic 60-day prior authorization approval for brand name mental health drugs when generic equivalents become available, and includes provisions that streamline authorization processes for specific drug scenarios, such as liquid medications and drugs prescribed for patients using enteral feeding tubes. Additionally, the bill maintains existing protections for HIV and AIDS medications, ensuring they remain free from prior authorization requirements. The changes aim to reduce barriers to mental health treatment by making it easier for patients to access necessary medications.

Health and Social Services, Labor and Employment

https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF2533&ssn=0&y=2025